This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pivlaz

Actelion Pharmaceuticals Ltd.

Drug Names(s): clazosentan, AVX-034343

Description: Clazosentan is a selective endotheline A receptor antagonist that prevents vasospasm.

Deal Structure: Clazosentan was licensed to Axovan from Roche in 2002, and Actelion acquired Axovan in 2003.

Partners: Roche Holding AG


Pivlaz News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug